Health TrialsbyHealthPanel

Clinical trials

11

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Tegoprazan-Aspirin Drug Interaction in Healthy Adult Male Volunteers

This Clinical Trial Aims to Evaluate the PK/PD Drug-Drug Interaction and Safety/Tolerability of Tegoprazan and Aspirin in Healthy Adult Male Volunteers.

Participants needed: 34
Trial details
Phase: Phase 1Age: 19-50Biological sex: MaleType: InterventionalSponsor: HK inno.N CorporationUpdated: Oct 1, 2026Locations: 1
Eligibility criteria

Healthy male adult volunteers aged ≥19 years and ≤50 years at the time of screen... [+4]

Participants who have or have a history of clinically significant hepatobiliary... [+25]

Read more
Status: Not yet recruiting

A Study to Evaluate Tegoprazan as a Diagnostic Tool for GERD

The purpose of this study is to evaluate the diagnostic value of tegoprazan for GERD. Patients experiencing typical GERD symptoms, such as heartburn and acid regurgitation, will take either tegoprazan or a placebo once daily for 1 week. Investigators will compare the short-term symptom improvement between the two groups to determine if an early response to tegoprazan can help diagnose GERD.

Participants needed: 100
Trial details
Phase: Phase 4Age: 19-75Biological sex: AllType: InterventionalSponsor: HK inno.N CorporationUpdated: Sep 17, 2026
Eligibility criteria

Patients aged 19 to 75 years who have experienced symptoms of acid regurgitation... [+2]

Known hypersensitivity to Potassium-Competitive Acid Blockers (P-CABs) or benzim... [+8]

Read more
Status: Recruiting

A Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients

This study aims to evaluate the efficacy and safety of IN-115314 Ointment in mild to moderate atopic dermatitis adult patients

Participants needed: 162
Trial details
Phase: Phase 2Age: 19+Biological sex: AllType: InterventionalSponsor: HK inno.N CorporationUpdated: Sep 9, 2026Locations: 1
Eligibility criteria

Adult volunteers aged 19 or older when the informed consent is obtained. [+3]

Subjects who have the following prior/current history in addition to evidence or... [+38]

Read more
Status: Recruiting

An Observational Study to Evaluate the Efficacy and Safety of K-CAB Tab./K-CAB ODT(Tegoprazan) in GERD Patients

This study aims to evaluate the status of AE and improvement effect of K-CAB Tab/K-CAB ODT(Tegoprazan) 50mg in patients with GERD.

Participants needed: 5,384
Trial details
Age: 19+Biological sex: AllType: ObservationalSponsor: HK inno.N CorporationUpdated: Jul 1, 2026Locations: 1
Eligibility criteria

Subjects over 19 years of age as of the date of consent [+2]

Subjects who have hypersensitivity reactions and a medical history of Benzimidaz... [+2]

Read more
Status: Not yet recruiting

A Study to Evaluate the Efficacy and Safety of IN-207907 Injection in Elderly Patients With Sarcopenia

The goal of this clinical trial is to learn if intervention can treat sarcopenia in the elderly. Researchers will compare IN-207907 120 mg, 240 mg, 360 mg and placebo to see if SPPB score improves.

Participants needed: 100
Trial details
Phase: Phase 2Age: 65+Biological sex: AllType: InterventionalSponsor: HK inno.N CorporationUpdated: Jun 25, 2026
Eligibility criteria

Subjects aged ≥ 65 years (for female subjects, those who are medically unable to... [+3]

Subjects with a history of diseases or surgical procedures that may affect physi... [+16]

Read more
Status: Not yet recruiting

A Study to Evaluate the Pharmacokinetics and Safety of IN-M00007 and IN-R00007 in Healthy Adult Volunteers

This study aims to evaluate the Pharmacokinetic (PK) characteristics and safety after a single oral dose administration of IN-M00007 and IN-R00007 in healthy adult volunteers

Participants needed: 60
Trial details
Phase: Phase 1Age: 19-59Biological sex: AllType: InterventionalSponsor: HK inno.N CorporationUpdated: Dec 31, 2025Locations: 1
Eligibility criteria

Healthy adult volunteers aged ≥ 19 and < 60 years at screening [+8]

Subjects who have taken drugs which can induce(e.g, Barbiturates) or inhibit dru... [+16]

Read more
Status: Not yet recruiting

Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone

This Phase 3 Bridge study is designed to evaluate the efficacy and safety of IN-B00009 Injection in Patients with T2DM Inadequately Controlled by Diet and Exercise Alone

Participants needed: 110
Trial details
Phase: Phase 3Age: 19-75Biological sex: AllType: InterventionalSponsor: HK inno.N CorporationUpdated: Dec 29, 2025
Eligibility criteria

Subjects aged 19 to 75 years at the time of written consent [+8]

Subjects who have been diagnosed with type 1 diabetes mellitus (T1DM) or diabete... [+39]

Read more
Status: Not yet recruiting

A Study to Evaluate the Pharmacokinetics and Food-effect of IN-M00002 Tablet in Healthy Adult Volunteers

This study aims to evaluate the pharmacokinetic (PK) following administration of IN-M00002 tablet and co-administration of tegoprazan and naproxen, and to evaluate food-effect of IN-M00002 tablet in healthy adult volunteers

Participants needed: 74
Trial details
Phase: Phase 1Age: 19-55Biological sex: AllType: InterventionalSponsor: HK inno.N CorporationUpdated: Dec 11, 2025Locations: 1
Eligibility criteria

Healthy adult aged ≥ 19 and ≤ 55 year-old at screening [+4]

Medical history or evidence of clinically significant blood, renal, endocrine, r... [+18]

Read more
Status: Not yet recruiting

Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes Mellitus

This Phase 3 study is designed to evaluate the efficacy and safety of IN-B00009 injection in adults with obesity or overweight without diabetes mellitus

Participants needed: 300
Trial details
Phase: Phase 3Age: 19-75Biological sex: AllType: InterventionalSponsor: HK inno.N CorporationUpdated: Sep 25, 2025
Eligibility criteria

Aged 19 to 75 years as of the date of written consent [+12]

Body weight change exceeding 5 kg within 3 months of the screening visit [+34]

Read more
Status: Not yet recruiting

This Study Aims to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties and Food Effect of IN-114199 in Healthy Participants

This study aims to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic properties and food effect of IN-114199 in healthy participants

Participants needed: 80
Trial details
Phase: Phase 1Age: 19-63Biological sex: AllType: InterventionalSponsor: HK inno.N CorporationUpdated: Dec 17, 2024Locations: 1
Eligibility criteria

Healthy adults aged ≥ 19 years and ≤ 63 years on the date of the written informe... [+4]

Presence or history of clinically significant liver, kidney, nervous system, res... [+13]

Read more
Status: Recruiting

Long-term Observational Study to Evaluate the DFS and OS of Adjuvant FOLFIRINOX Regimen in Pancreatic Cancer Patients

This study is designed to evaluate the safety and efficacy of adjuvant FOLFIRINOX regimen in pancreatic cancer patients after curative surgery.

Participants needed: 36
Trial details
Age: 19+Biological sex: AllType: ObservationalSponsor: HK inno.N CorporationUpdated: Apr 29, 2024Locations: 1
Eligibility criteria

Age over 19 at the time of obtaining the informed consent form [+4]

FOLFIRINOX contraindications among the drug approval requirements [+2]

Read more